BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

NeuralStem Inc. 

387 Technology Drive

College Park  Maryland  20742  U.S.A.
Phone: 301-314-2671 Fax: 301-405-1064


SEARCH JOBS


Industry
Biotechnology






 Company News
NeuralStem Inc. Spinal Cord Injury Stem Cell Trial Approved To Commence At University of California, San Diego (UCSD) 4/16/2014 9:36:53 AM    More...
NeuralStem Inc. Principal Investigator, Dr. Eva Feldman, To Present Published ALS Trial Phase I Data At Medical Conference 4/7/2014 7:40:44 AM    More...
Final Results Of NeuralStem Inc. Phase I Stem Cell Trial In Amyotrophic Lateral Sclerosis Published In Annals of Neurology 3/17/2014 10:22:37 AM    More...
NeuralStem Inc. Announces 2013 Financial Results 3/10/2014 8:06:12 AM    More...
NeuralStem Inc. President And CEO To Present NSI-566 Clinical Trials Program Update At Biotechnology Industry Organization (BIO) CEO & Investor Conference 2014 2/6/2014 8:31:03 AM    More...
NeuralStem Inc. Appoints Catherine Angell Sohn To Board Of Directors 1/14/2014 7:54:10 AM    More...
First Patient Treated In NeuralStem Inc. China Stem Cell Trial To Treat Stroke Motor Deficits 1/13/2014 12:06:47 PM    More...
NeuralStem Inc. To Raise $19.65 Million In Registered Direct Offering 1/3/2014 7:28:58 AM    More...
NeuralStem Inc. Release: Dr. Eva Feldman, Principal Investigator, to Give Update on ALS Trial at American Neurological Association Meeting 10/10/2013 8:17:21 AM    More...
University of Michigan Health System Treats Its First Patients in NeuralStem Inc.'s Phase II ALS Stem Cell Trial 10/9/2013 10:20:11 AM    More...
12345678910...

//-->